Synopsis
Alan, a French health tech company, has successfully attracted a whopping $460 million investment from the Netherlands-based Prosus, elevating its valuation to an impressive $6.3 billion. This funding will significantly enhance Alan's growth efforts, promoting global expansion and driving innovation in AI-powered products. Additionally, the agreement grants Alan access to Prosus's Large Commerce Model, enabling improved health insurance and telehealth services in its existing markets.Listen to this article in summarized format
Alan operates in France, Canada, Belgium and Spain and offers services such as health insurance and telehealth. The company has an annual recurring revenue of 800 million euros ($909.04 million) as of the first quarter of 2026.
* The investment will consist of both primary and secondary equity
* It will help drive Alan's expansion in international markets and accelerate its AI-led product development
* Prosus will also provide Alan with access to its Large Commerce Model
* The transaction's closing is subject to applicable regulatory approvals, including from French financial authorities
($1 = 0.8800 euros)
